Positron emission tomography with 18-fluorodeoxyglucose in the staging and follow-up of lymphoma in the chest

Acta Oncologica

Volumn 38, Issue 6, 1999, Pages 799-804

  Bangerter, Markus ^a   Kotzerke, Jörg ^a   Griesshammer, Martin ^a   Elsner, Klaus ^a   Reske, Sven Norbert ^a   Bergmann, Lothar ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SCINTISCANNING; CANCER STAGING; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; LYMPHOMA; MALE; MEDIASTINAL NEOPLASMS; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; THORACIC NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0032848979     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/028418699432969     Document Type: Article

References (47)

1. Front D. Israel O, Epelbaum R, et al. Ga 67 SPECT before and after treatment of lymphoma. Radiology 1990; 175: 515-9.
2. Wylie BR, Soutee AE, Joshua DE, et al. Gallium scanning in the management of mediastinal Hodgkin's disease. Eur J Haematol 1989; 42: 344-7.
3. Front D, Bar-Shalom R, Epelbaum R, et al. Early detection of lymphoma recurrence with gallium-67 scintigraphy. J Nucl Med 1993; 34: 2101-4.
4. Israel O, Front D, Lam M, et al. Gallium 67 imaging in monitoring lymphoma response to treatment. Cancer 1988; 61: 2439-43.
5. Front D, Israel O, Epelbaum R, et al. Ga 67 SPECT before and alter treatment of lymphoma. Radiology 1990; 175: 515-9.
6. Kaplan WD, Jochelson MS, Herman TS, et al. Gallium 67 imaging: a predictor of residual tumor viability and clinical outcome in patients with diffuse large-cell lymphoma. J Clin Oncol 1990; 8: 1966-70.
7. King SC, Reiman RJ, Prosnitz LR. Prognostic importance of restaging gallium scans following induction chemotherapy for advanced Hodgkin's disease. J Clin Oncol 1994; 12: 306-11.
8. Vose JM, Bierman PJ, Anderson JR, et al. Single photon emission computed tomography gallium imaging versus computed tomography: predictive value in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation for non-Hodgkin's lymphoma. J Clin Oncol 1996; 14: 2473-9.
9. Anderson KC, Leonard RC, Canellos GP, et al. High-dose gallium imaging in lymphoma. Am J Med 1983; 75: 327-31.
10. Larcos G, Farlow DC, Antico VF, et al. The role of high-dose 67-gallium scintigraphy in staging untreated patients with lymphoma. Aust NZ J Med 1994; 24: 5-8.
11. Longo DL, Schilsky RL, Blei L, et al. gallium-67 scanning: limited usefulness in staging patients with non-Hodgkin's lymphoma. Am J Med 1980; 68: 695-700.
12. Tumeh SS, Rosenthal DS, Kaplan WD, et al. Lymphoma: evaluation with Ga-67 SPECT. Radiology 1987; 164: 111-4.
13. Chapman PE, Groshar D, Hooper HR, et al. Does gallium uptake in the pulmonary hila predict involvement by non-Hodgkin's lymphoma? Nucl Med Commun 1992; 13: 730-7.
14. Kaplan WD, Soutee AE, Annese ML, et al. Evaluating low and intermediate grade non-Hodgkin's lymphoma with gallium-67 and thalluim-201 imaging (abstr). J Nucl Med 1990; 31: 793.
15. Even-Sapir E, Bar-Shalom R, Israel O, et al. Single-photon emission computed tomography quantitation of gallium citrate uptake for the differentiation of lymphoma from benign hilar uptake. J Clin Oncol 1995; 13: 942-6.
16. Yonekura Y, Benua RS, Brill P, et al. Increased accumulation of 2-deoxy-2-[18F]fluoro-D-glucose in liver metastases from colon carcinoma. J Nucl Med 1982; 23: 1133-7.
17. DiChiro G. Positron emission tomography using [18F]fluorodeoxyglucose in brain tumors: a powerful diagnostic and prognostic tool. Invest Radiol 1986; 22: 360-71.
18. Alavi JB, Alavi A, Chawluk J, et al. Positron emission tomography in patients with glioma: a predictor of prognosis. Cancer 1988; 62: 1074-8.
19. Strauss LG, Conti PS. The applications of PET in clinical oncology. J Nucl Med 1993; 32: 623-48.
20. Moog F, Bangerter M, Diederichs CG, et al. Lymphoma: Role of whole-body 2-deoxy-2 [F-18]fluoro-D-glucose (FDG) PET in nodal staging. Radiology 1997; 203: 795-800.
21. Newmann JS, Francis IR, Kaminski MS, et al. Imaging of lymphoma with PET with 2-[F18]-fluoro-2-deoxy-D-glucose: correlation with CT. Radiology 1994; 190: 111-6.
22. Okada J, Oonishi H, Yoshikawa K, et al. FDG-PET for predicting the prognosis of malignant lymphoma. Ann Nucl Med 1994; 8: 187-91.
23. Hoh CK, Hawkins RA, Glaspy JA, et al. Cancer detection with whole-body PET using 2-[18F]fluoro-2 deoxy-D-glucose. J Comput Assist Tomogr 1993; 17: 582-9.
24. De Wit M, Bumann D, Beyer W, et al. Whole-body positron emission tomography (PET) for diagnosis of residual mass in patients with lymphoma. Ann Oncol 1997; 8: 57-60.
25. Moog F, Bangerter M, Diederichs CG, et al. Extranodal malignant lymphoma: detection with FDG PET versus CT. Radiology 1998; 206: 475-81.
26. Hoh CK, Glaspy J, Rosen P, et al. Whole-body FDG-PET imaging for staging of Hodgkin's disease and lymphoma. J Nucl Med 1997; 38: 343-8.
27. Lapela M, Leskinen S, Minn HR, et al. Increased glucose metabolism in untreated non-Hodgkin's lymphoma: a study with positron emission tomography and fluorine-18-fluorodeoxyglucose. Blood 1995; 86: 3522-7.
28. Moog F, Bangerter M, Kotzerke J, et al. 18-F-fluorodeoxyglucose-positron emission tomography as a new approach to detect lymphomatous bone marrow. J Clin Oncol 1998; 16: 603-9.
29. Hockstra OS, Ossenkoppele GJ, Golding R, et al. Early treatment response in malignant lymphoma, as determined by planar fluorine-18-fluorodeoxyglucose scintigraphy. J Nucl Med 1993; 34: 1706-10.
30. Leskinen-Kallio S, Ruotsalainen U, Nagren K, et al. Uptake of carbon-11-methionine and fluorodeoxyglucose in non-Hodgkin's lymphoma: a PET study. J Nucl Med 1991; 32: 1211-8.
31. Inoue T, Kim EE, Komaki R, et al. Detecting recurrent or residual lung cancer with FDG-PET. J Nucl Med 1995; 36: 788-93.
32. Neumann DR, Esselstyn CB, MacIntrye WJ, et al. Regional FDG-PET in postoperative recurrent hyperparathyroidism. J Comput Assist Tomogr 1997; 21; 25-8.
33. Knight SB, Delbeke D, Stewart JR, et al. Evaluation of pulmonary lesions with FDG-PET. Chest 1996; 109; 982-8.
34. Weinblatt ME, Zanzi I, Belakhlef A, et al. False-positive FDG-PET imaging of the thymus of a child with Hodgkin's disease. J Nucl Med 1997; 38: 888-90.
35. Ho CL, Dehdashti F, Griffeth LK, et al. FDG-PET evaluation of indeterminate pancreatic masses. J Comput Assist Tomogr 1996; 20: 363-9.
36. Buchpiquel CA, Alavi JB, Alavi A, et al. PET versus SPECT in distinguishing radiation necrosis from tumor recurrence in the brain. J Nucl Med 1995; 36; 159-64.
37. Guhlmann A. Brecht-Krauss D, Super G, et al. Chronic osteomyelitis: detection with FDG PET and correlation with histopathologic findings. Radiology 1998; 206: 749-54.
38. Rosenberg SA, Berard CW, Brown BW, et al. National Cancer Institute sponsored study of classification of non- Hodgkin's lymphomas: summary and description of a working formulation for clinical use. Cancer 1982; 49: 2112-35.
39. Schmidlin P. Improved iterative image reconstruction using variable projection binning and abbreviated convolution. Eur J Nucl Med 1994; 21: 930-6.
40. Keyes JW-Jr. SUV, standard uptake or silly useless value? J Nucl Med 1995; 36: 1836-9.
41. North LB, Libshitz HI, Lorigan JG. Thoracic lymphoma. Radiol Clin North Am 1990; 24: 745-62.
42. Peylan-Ramu N, Haddy TB, Jones E, et al. High frequency of benign mediastinal uptake of Gallium-67 after completion of chemotherapy in children with high-grade non Hodgkin's lymphoma. J Clin Oncol 1989; 7: 1800-6.
43. Jones HA, Clark RJ, Rhodes CG, et al. In vivo measurement of neutrophil activity in experimental lung inflammation. Am J Respir Crit Care Med 1994; 149: 1635-9.
44. Hoffmann JM, Waskin HA. Hanson MW, et al. FDG-PET in differentiating lymphoma from nonmalignant central nervous system lesions in patients with AIDS. J Nucl Med 1993; 34: 567-75.
45. Lowe VJ, Hoffmann JM, DeLong DM, et al. Semiquantitaive and visual analysis of FDG-PET images in pulmonary abnormalities. J Nucl Med 1994; 35: 1771-6.
46. Wegener OH. Mediastinum. In: Ganzkörpercomputertomographie. 2nd ed. Berlin, Germany: Blackwell, 1992: 141-3.
47. Castellino R, Hoppe R, Blank N, et al. Computed tomography, lymphography and staging laparotomy: correlations in initial staging of Hodgkin's disease. AJR 1984; 143: 37-41.